VTRS News and Press, Viatris Inc. From 12/14/23

2023-12-14 14:26:24 ET More on AbbVie, AstraZeneca, etc. GSK - Greenshoots In The Horizon AstraZeneca: A $1.1B Shot In The Arm From Icosavax Acquisition AstraZeneca Is Feeling The Weight Of The Market In 2023 AbbVie, Amgen among firms targeted for latest Medi...

2023-12-12 11:07:43 ET Summary Investors should consider tax-loss selling before December ends to offset capital gains. Two characteristics to consider for selling stocks are stocks bought at a higher price and broken companies with weak long-term prospects. Stock grades, sent...

2023-11-30 07:30:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips After a rocky couple of years, there finally seems to be some light at the end of the tunnel for growth stocks . Interest rates have stabilized, and the economy is again showing signs of st...

2023-11-24 04:34:34 ET Summary Viatris shares had a negative 25% total return in the past 2 years, underperforming the S&P 500. The decline is likely due to the company's debt burden and stagnant revenues. Despite this, now may be a good time to consider buying VTRS as its...

Community Activity Part of Company's Impact Week Anniversary Celebration PITTSBURGH, PA / ACCESSWIRE / November 21, 2023 / Viatris (NASDAQ:VTRS), a global healthcare company, today announced that it has packed 1,000 backpacks in partnership with Comfort Cases, a nonprofit organization th...

2023-11-21 13:48:38 ET Summary VTRS reported Q3-2023 earnings in line with estimates, with total sales down 3.3%. Adjusted EBITDA fell again, and new product launches are not delivering the same margins as the old business. We look at the progress made since its listing and te...

2023-11-19 02:00:00 ET Summary Legend Biotech partners with Novartis in a $1.2 billion deal to develop and commercialize DLL3 CAR-T candidates. WuXi XDC, an ADC/bioconjugate CRDMO, raises $520 million in a successful IPO in Hong Kong. Shanghai SciClone Pharma acquires China ri...

2023-11-15 13:59:19 ET More on Vertex Pharma Vertex Pharmaceuticals Incorporated (VRTX) Jefferies Global Healthcare Conference Call Transcript Vertex Pharmaceuticals Incorporated (VRTX) Presents at UBS Biopharma Conference (Transcript) No Dividend, No Problem: Vertex...

Viatris to Participate in the Jefferies London Healthcare Conference PR Newswire PITTSBURGH , Nov. 14, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the Jefferies London Healthca...

Viatris and Theravance Biopharma Announce Positive Top-Line Results from YUPELRI® (revefenacin) Phase III Trial in China for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) PR Newswire Top-line results from Phase III study in China demonstrate the effica...